The results showed that NTRK3 in BLCA has a significant positive correlation with chemokine CCL14, immunoinhibitor ADORA2A, and immunostimulator CXCL12 (Figs. 6c, d and e). Here, NTRK3 is linked to bladder transitional cell carcinoma.